Literature DB >> 30793658

Breastfeeding and post-partum relapses in multiple sclerosis patients.

Emilio Portaccio1, Maria Pia Amato2.   

Abstract

While it is acknowledged that exclusive breastfeeding has well-established benefits for both infant/child and mother health, evidence on the relationships between breastfeeding and disease course in women with multiple sclerosis (MS) is still controversial. On one hand, in the post-partum period, a disease worsening is possible, particularly in women with more active MS. On the other hand, the use of disease modifying drugs is currently contraindicated during lactation. In this topical review, we describe available evidence on the relationship between breastfeeding and disease activity in MS. In some studies, a possible protective role for exclusive breastfeeding against the risk of post-partum relapse has been suggested, while, in others, its impact was neutral. Waiting for definitive evidence on this topic, we propose a pragmatic approach to breastfeeding choice, on a case-by-case basis, considering the disease characteristics before and during pregnancy and the patient therapeutic history.

Entities:  

Keywords:  Multiple sclerosis; breastfeeding; post-partum relapse; pregnancy

Mesh:

Year:  2019        PMID: 30793658     DOI: 10.1177/1352458519830588

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes.

Authors:  Andrea Ines Ciplea; Annette Langer-Gould; Anna Stahl; Sandra Thiel; Annette Queisser-Wahrendorf; Ralf Gold; Kerstin Hellwig
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-20

Review 2.  Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy.

Authors:  Ramón Villaverde-González
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-01-05

Review 3.  Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review.

Authors:  Fioravante Capone; Angela Albanese; Giorgia Quadri; Vincenzo Di Lazzaro; Emma Falato; Antonio Cortese; Laura De Giglio; Elisabetta Ferraro
Journal:  Front Neurol       Date:  2022-04-15       Impact factor: 4.003

4.  Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis - COBRA study.

Authors:  Andrea Ines Ciplea; Anna Kurzeja; Sandra Thiel; Sabrina Haben; Jessica Alexander; Evelyn Adamus; Kerstin Hellwig
Journal:  Mult Scler       Date:  2022-04-01       Impact factor: 5.855

Review 5.  Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.

Authors:  Isabella Laura Simone; Carla Tortorella; Alma Ghirelli
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.